| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
2,145 |
1,775 |
$194K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,587 |
1,380 |
$97K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,853 |
1,584 |
$88K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
1,194 |
947 |
$60K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
1,129 |
903 |
$57K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
589 |
542 |
$34K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
727 |
692 |
$32K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,865 |
858 |
$18K |
| 99205 |
Prolong outpt/office vis |
151 |
112 |
$17K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
1,533 |
1,382 |
$15K |
| 99215 |
Prolong outpt/office vis |
65 |
59 |
$6K |
| 87807 |
|
43 |
39 |
$354.00 |
| 81002 |
|
129 |
110 |
$227.44 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
13 |
12 |
$191.97 |
| 81001 |
|
15 |
12 |
$22.55 |